Excel Industries Reports Strong FY26 Performance with ₹73 Crore Profit

Excel Industries has announced its Q4 and full fiscal year FY26 earnings, reporting a standalone revenue of ₹1,094 crore and a Profit After Tax (PAT) of ₹73 crore for the fiscal year ended March 31, 2026.

Reader Takeaway: Revenue and profit growth in Q4 FY26; dividend payout despite agrochemical headwinds.

What just happened

Excel Industries announced its financial results for the fourth quarter and the full fiscal year 2026. For the full year FY26, the company recorded a standalone revenue of ₹1,094 crore, a notable increase from ₹978 crore in FY25. The Profit After Tax (PAT) for FY26 stood at ₹73 crore, up from the previous year. In the fourth quarter of FY26 (Q4 FY26), standalone revenue grew to ₹281 crore from ₹248 crore in Q4 FY25, a 13% year-on-year jump. PAT for Q4 FY26 also saw a significant rise of 18.2%, reaching ₹13 crore compared to ₹11 crore in the same quarter last year.

Why this matters

The results indicate a recovery in the company's performance, particularly in the fourth quarter, after a challenging first half of FY26. The company highlighted its net cash positive status and the absence of long-term debt, which strengthens its financial position. Furthermore, the declaration of a ₹13.75 per equity share dividend (275% of face value) signals a commitment to returning value to shareholders. Management's strategic focus on growing exports and contract manufacturing, while consolidating its position in phosphorus chemistry, is a key long-term driver.

The backstory

The first half of FY26 was impacted by agrochemical headwinds, including disruptions in sowing and harvest cycles, leading to demand uncertainty. This made the Q4 recovery particularly significant. The company's strategy to de-risk by shifting focus from agrochemical intermediates towards more stable segments like contract manufacturing and performance solutions is an ongoing strategic pivot.

What changes now

Excel Industries plans to invest ₹200-300 crore in capital expenditure over the next 2-3 years, aiming for a 15-20% Return on Investment (ROI). This investment is geared towards scaling up contract manufacturing and performance solutions. Investors will be looking for execution of this capex plan and its impact on future revenue streams and profitability.

Risks to watch

Key risks include potential headwinds in the agrochemical sector due to monsoon forecasts, and supply chain disruptions stemming from geopolitical factors affecting raw material availability and pricing for Q1 FY27. A significant watch point is the ongoing anti-dumping investigation for HCDP and ATMP, initiated in September 2025, with findings expected by September 2026. The financial impact of this investigation remains unquantified.

Peer comparison

While specific peer financial data is not provided in the filing, Excel Industries operates in the specialty chemicals sector. Companies in this space often face similar challenges related to raw material price volatility, regulatory investigations, and cyclical demand, especially in agrochemicals. Excel's focus on contract manufacturing offers a diversification strategy within the specialty chemicals landscape.

Context metrics (time-bound)

• FY26 Standalone Revenue: ₹1,094 crore (vs. ₹978 crore in FY25)
• FY26 Standalone PAT: ₹73 crore
• Q4 FY26 Standalone Revenue: ₹281 crore (vs. ₹248 crore in Q4 FY25, +13%)
• Q4 FY26 PAT: ₹13 crore (vs. ₹11 crore in Q4 FY25, +18.2%)
• Dividend Declared: ₹13.75 per equity share
• Capex Plan: ₹200-300 crore over 2-3 years
• Anti-dumping investigation initiated: September 2025; findings expected September 2026.

What to track next

Investors should closely monitor the progress and impact of the planned capital expenditure, the company's ability to navigate agrochemical demand uncertainty driven by monsoons, and developments in the anti-dumping investigation for HCDP and ATMP. Management's execution on its strategy to grow exports and scale contract manufacturing will be crucial.